A previous study reported that icariin (ICA) alleviated Alzheimer’s disease pathology by regulating the expression of MEG3 and MALAT1 lncRNAs and modulating the AKT/GSK3β signaling pathway [28]. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.